Insulin Autoimmune Syndrome (Hirata Disease): A Comprehensive Review Fifty Years After Its First Description

References

• Hirata Y, Ishizu H, Ouchi N. Insulin autoimmunity in a case of spontaneous hypoglycemia. J Jpn Diabetes Soc. 1970;13:312–320.
   Google Scholar
• De Pirro R, Roth RA, Rossetti L, Goldfine ID. Characterization of the serum from a patient with insulin resistance and hypoglycemia. Evidence for multiple populations of insulin receptor antibodies with different receptor binding and insulin-mimicking activities. Diabetes. 1984;33(3):301–304. doi:10.2337/diab.33.3.301
   PubMedGoogle Scholar
• Lupsa BC, Chong AY, Cochran EK, Soos MA, Semple RK, Gorden P. Autoimmune forms of hypoglycemia. Medicine (Baltimore). 2009;88(3):141–153. doi:10.1097/MD.0b013e3181a5b42e
   PubMed Web of Science ®Google Scholar
• Censi S, Mian C, Betterle C. Insulin autoimmune syndrome: from diagnosis to clinical management. Ann Transl Med. 2018;6(17):335. doi:10.21037/atm
   PubMedGoogle Scholar
• Ishizuka T, Ogawa S, Mori T, et al. Characteristics of the antibodies of two patients who developed daytime hyperglycemia and morning hypoglycemia because of insulin antibodies. Diabetes Res Clin Pract. 2009;84(2):e21–e23. doi:10.1016/j.diabres.2009.02.007
   PubMedGoogle Scholar
• Cryer PE, Axelrod L, Grossman AB, et al. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2009;94(3):709–728. doi:10.1210/jc.2008-1410
   PubMed Web of Science ®Google Scholar
• Hirata Y. Insulin Autoimmune Syndrome - the second case. J Jpn Diabetes Soc. 1972;15:187–192.
   Google Scholar
• Folling I, Norman N. Hyperglycemia, hypoglycemic attacks, and production of anti-insulin antibodies without previous known immunization. Immunological and functional studies in a patient. Diabetes. 1972;21(7):814–826. doi:10.2337/diab.21.7.814
   PubMedGoogle Scholar
• Hirata Y, Tominaga M, Ito JI, Noguchi A. Spontaneous hypoglycemia with insulin autoimmunity in Graves’ disease. Ann Intern Med. 1974;81(2):214–218. doi:10.7326/0003-4819-81-2-214
   PubMedGoogle Scholar
• Oneda A, Matsuda K, Sato M, Yamagata S, Sato T. Hypoglycemia due to apparent autoantibodies to insulin. Characterization of insulin-binding protein. Diabetes. 1974;23(1):41–50. doi:10.2337/diab.23.1.41
   PubMedGoogle Scholar
• Hirata Y. Methimazole and insulin autoimmune syndrome with hypoglycemia. Lancet (London, England). 1983;2(8357):1037–1038. doi:10.1016/S0140-6736(83)91031-0
   PubMedGoogle Scholar
• Uchigata Y, Kuwata S, Tokunaga K, et al. Strong association of insulin autoimmune syndrome with HLA-DR4. Lancet (London, England). 1992;339(8790):393–394. doi:10.1016/0140-6736(92)90080-M
   PubMed Web of Science ®Google Scholar
• Uchigata Y, Hirata Y, Omori Y. A novel concept of type VII hypersensitivity introduced by insulin autoimmune syndrome (Hirata’s disease). Autoimmunity. 1995;20(3):207–208. doi:10.3109/08916939508993352
   PubMed Web of Science ®Google Scholar
• Uchigata Y, Hirata Y, Iwamoto Y. Drug-induced insulin autoimmune syndrome. Diabetes Res Clin Pract. 2009;83(1):e19–e20. doi:10.1016/j.diabres.2008.10.015
   PubMedGoogle Scholar
• Ismail AA. The insulin autoimmune syndrome (IAS) as a cause of hypoglycaemia: an update on the pathophysiology, biochemical investigations and diagnosis. Clin Chem Lab Med. 2016;54(11):1715–1724. doi:10.1515/cclm-2015-1255
   PubMed Web of Science ®Google Scholar
• Takayama-Hasumi S, Eguchi Y, Sato A, Morita C, Hirata Y. Insulin autoimmune syndrome is the third leading cause of spontaneous hypoglycemic attacks in Japan. Diabetes Res Clin Pract. 1990;10(3):211–214. doi:10.1016/0168-8227(90)90063-Y
   PubMedGoogle Scholar
• Yamada Y, Kitayama K, Oyachi M, et al. Nationwide survey of endogenous hyperinsulinemic hypoglycemia in Japan (2017-2018): congenital hyperinsulinism, insulinoma, non-insulinoma pancreatogenous hypoglycemia syndrome and insulin autoimmune syndrome (Hirata’s disease). J Diabetes Investig. 2019. doi:10.1111/jdi.13180
   Google Scholar
• Woo CY, Jeong JY, Jang JE, et al. Clinical features and causes of endogenous hyperinsulinemic hypoglycemia in Korea. Diabetes Metab J. 2015;39(2):126–131. doi:10.4093/dmj.2015.39.2.126
   PubMed Web of Science ®Google Scholar
• Wang YL, Yao PW, Zhang XT, Luo ZZ, Wu PQ, Xiao F. Insulin autoimmune syndrome: 73 cases of clinical analysis. Chin Med J (Engl). 2015;128(17):2408–2409. doi:10.4103/0366-6999.163376
   PubMedGoogle Scholar
• Uchigata Y, Hirata Y, Omori Y, Iwamoto Y, Tokunaga K. Worldwide differences in the incidence of insulin autoimmune syndrome (Hirata disease) with respect to the evolution of HLA-DR4 alleles. Hum Immunol. 2000;61(2):154–157. doi:10.1016/S0198-8859(99)00144-5
   PubMed Web of Science ®Google Scholar
• Hirata Y, Uchigata Y. Insulin autoimmune syndrome in Japan. Diabetes Res Clin Pract. 1994;24(Suppl):S153–S157. doi:10.1016/0168-8227(94)90243-7
   PubMedGoogle Scholar
• Uchigata Y, Eguchi Y, Takayama-Hasumi S, Omori Y. Insulin autoimmune syndrome (Hirata disease): clinical features and epidemiology in Japan. Diabetes Res Clin Pract. 1994;22(2–3):89–94. doi:10.1016/0168-8227(94)90040-X
   PubMedGoogle Scholar
• Lee SH, Oh SH, Chung WY. Insulin autoimmune syndrome induced by methimazole in a Korean girl with Graves’ disease. Ann Pediatr Endocrinol Metab. 2013;18(1):32–35. doi:10.6065/apem.2013.18.1.32
   PubMedGoogle Scholar
• Alves C, Constanca J, De Leon DD, Snider K, Stanley C. A novel atypical presentation of insulin autoimmune syndrome (Hirata’s disease) in a child. J Pediatr Endocrinol Metab. 2013;26(11–12):1163–1166. doi:10.1515/jpem-2013-0215
   PubMedGoogle Scholar
• Su CT, Lin YC. Hyperinsulinemic hypoglycemia associated with insulin antibodies caused by exogenous insulin analog. Endocrinol Diabetes Metab Case Rep. 2016;2016:16–0079.
   PubMedGoogle Scholar
• Kobayashi S, Amano H, Kawaguchi Y, Yokoo T. A novel treatment of hyperinsulinemic hypoglycemia induced by insulin antibodies with alkali administration: a case report. J Med Case Rep. 2019;13(1):79. doi:10.1186/s13256-019-1989-8
   PubMedGoogle Scholar
• Chen F, Yang J, Liu Y, et al. Insulin autoimmune syndrome: three case reports. Medicine (Baltimore). 2018;97(51):e13486. doi:10.1097/MD.0000000000013486
   PubMedGoogle Scholar
• Betterle C, Zanchetta R. Update on autoimmune polyendocrine syndromes (APS). Acta Biomed. 2003;74(1):9–33.
   PubMedGoogle Scholar
• Takei M. Insulin auto-antibodies produced by methimazole treatment in the patients with the Graves’ disease. J Tokyo Women’s Med Coll. 1980;50:54.
   Google Scholar
• Uchigata Y, Omori Y, Nieda M, Kuwata S, Tokunaga K, Juji T. HLA-DR4 genotype and insulin-processing in insulin autoimmune syndrome. Lancet (London, England). 1992;340(8833):1467. doi:10.1016/0140-6736(92)92654-X
   PubMedGoogle Scholar
• Uchigata Y, Tokunaga K, Nepom G, et al. Differential immunogenetic determinants of polyclonal insulin autoimmune syndrome (Hirata’s disease) and monoclonal insulin autoimmune syndrome. Diabetes. 1995;44(10):1227–1232. doi:10.2337/diab.44.10.1227
   PubMed Web of Science ®Google Scholar
• Uchigata Y, Kuwata S, Tsushima T, et al. Patients with Graves’ disease who developed insulin autoimmune syndrome (Hirata disease) possess HLA-Bw62/Cw4/DR4 carrying DRB1*0406. J Clin Endocrinol Metab. 1993;77(1):249–254. doi:10.1210/jcem.77.1.8325948
   PubMedGoogle Scholar
• Uchigata Y. The novel agent, alpha lipoic acid, can cause the development of insulin autoimmune syndrome. Intern Med. 2007;46(17):1321–1322. doi:10.2169/internalmedicine.46.0221
   PubMedGoogle Scholar
• Gullo D, Evans JL, Sortino G, Goldfine ID, Vigneri R. Insulin autoimmune syndrome (Hirata Disease) in European Caucasians taking alpha-lipoic acid. Clin Endocrinol (Oxf). 2014;81(2):204–209. doi:10.1111/cen.12334
   PubMedGoogle Scholar
• Cappellani D, Sardella C, Campopiano MC, Falorni A, Marchetti P, Macchia E. Spontaneously remitting insulin autoimmune syndrome in a patient taking alpha-lipoic acid. Endocrinol Diabetes Metab Case Rep. 2018;2018:18–0122.
   PubMedGoogle Scholar
• Reis MZR, Fernandes VO, Fontenele EGP, et al. Insulin autoimmune syndrome in an occidental woman: a case report and literature review. Arch Endocrinol Metab. 2018;62(5):566–570. doi:10.20945/2359-3997000000078
   PubMedGoogle Scholar
• Zhang Y, Zhao T. Hypoglycemic coma due to insulin autoimmune syndrome induced by methimazole: a rare case report. Exp Ther Med. 2014;8(5):1581–1584. doi:10.3892/etm.2014.1964
   PubMed Web of Science ®Google Scholar
• Basu A, Service FJ, Yu L, Heser D, Ferries LM, Eisenbarth G. Insulin autoimmunity and hypoglycemia in seven white patients. Endocr Pract. 2005;11(2):97–103. doi:10.4158/EP.11.2.97
   PubMedGoogle Scholar
• Hakamata M, Itoh M, Sudo Y, Miyata N. Insulin autoimmune syndrome after the third therapy with methimazole. Intern Med. 1995;34(5):410–412. doi:10.2169/internalmedicine.34.410
   PubMedGoogle Scholar
• Jain N, Savani M, Agarwal M, Kadaria D. Methimazole-induced insulin autoimmune syndrome. Ther Adv Endocrinol Metab. 2016;7(4):178–181. doi:10.1177/2042018816658396
   PubMedGoogle Scholar
• Gomez Cruz MJ, Jabbar M, Saini N, et al. Severe hypoglycemia secondary to methimazole-induced insulin autoimmune syndrome in a 16 year old African-American male. Pediatr Diabetes. 2012;13(8):652–655. doi:10.1111/pedi.2012.13.issue-8
   PubMedGoogle Scholar
• Virally ML, Timsit J, Chanson P, Warnet A, Guillausseau PJ. Insulin autoimmune syndrome: a rare cause of hypoglycaemia not to be overlooked. Diabetes Metab. 1999;25(5):429–431.
   PubMedGoogle Scholar
• Mettananda C, de Silva HJ, Fernando R. Hypoglycaemia and fits in a thyrotoxic man. BMJ Case Rep. 2009;2009. doi:10.1136/bcr.07.2008.0448
   PubMedGoogle Scholar
• Wong ST, Ng WY, Thai AC. Case report: autoimmune insulin syndrome in a Chinese female with Graves’ disease. Ann Acad Med Singapore. 1996;25(6):882–885.
   PubMedGoogle Scholar
• Lu CC, Lee JK, Lam HC, Yang CY, Han TM. Insulin autoimmune syndrome in a patient with methimazole and carbimazole-treated Graves’ disease: a case report. Zhonghua Yi Xue Za Zhi (Taipei). 1994;54(5):353–358.
   PubMedGoogle Scholar
• Armitage M, Franklyn J, Scott-Morgan L, et al. Insulin autoantibodies in Graves’ disease–before and after carbimazole therapy. Diabetes Res Clin Pract. 1990;8(3):169–176. doi:10.1016/0168-8227(90)90113-8
   PubMedGoogle Scholar
• Lin HD, Chen HD, Chang PY, Lin CY, Ching KN. Insulin autoimmune syndrome in methimazole or carbimazole treated Chinese patients of Graves’ disease. Zhonghua Yi Xue Za Zhi (Taipei). 1988;42(3):163–168.
   PubMedGoogle Scholar
• Furukawa N, Miyamura N, Nishida K, Motoshima H, Taketa K, Araki E. Possible relevance of alpha lipoic acid contained in a health supplement in a case of insulin autoimmune syndrome. Diabetes Res Clin Pract. 2007;75(3):366–367. doi:10.1016/j.diabres.2006.07.005
   PubMedGoogle Scholar
• Takeuchi Y, Miyamoto T, Kakizawa T, Shigematsu S, Hashizume K. Insulin Autoimmune Syndrome possibly caused by alpha lipoic acid. Intern Med. 2007;46(5):237–239. doi:10.2169/internalmedicine.46.1893
   PubMedGoogle Scholar
• Izzo V, Greco C, Corradini D, et al. Insulin autoimmune syndrome in an Argentine woman taking alpha-lipoic acid: A case report and review of the literature. SAGE Open Med Case Rep. 2018;6:2050313X18819601.
   PubMedGoogle Scholar
• Bresciani E, Bussi A, Bazzigaluppi E, Balestrieri G. Insulin autoimmune syndrome induced by alpha-lipoic acid in a Caucasian woman: case report. Diabetes Care. 2011;34(9):e146. doi:10.2337/dc11-0600
   PubMedGoogle Scholar
• Ishida Y, Ohara T, Okuno Y, et al. Alpha-lipoic acid and insulin autoimmune syndrome. Diabetes Care. 2007;30(9):2240–2241. doi:10.2337/dc07-0689
   PubMedGoogle Scholar
• Archambeaud-Mouveroux F, Canivet B, Fressinaud C, de Buhan B, Treves R, Laubie B. Autoimmune hypoglycemia: the fault of pyritinol? Presse Med. 1988;17(34):1733–1736.
   PubMedGoogle Scholar
• Canivet B, Archambeaud F. Pyrithioxine and hypoglycemic autoimmune syndrome. Autoimmunity. 1988;1(4):321–322. doi:10.3109/08916938809010686
   PubMedGoogle Scholar
• Deguchi A, Okauchi Y, Suehara S, Mineo I. Insulin autoimmune syndrome in a health supplement user: the effectiveness of cornstarch therapy for treating hypoglycemia. Intern Med. 2013;52(3):369–372. doi:10.2169/internalmedicine.52.7844
   PubMedGoogle Scholar
• Blackshear PJ, Rotner HE, Kriauciunas KA, Kahn CR. Reactive hypoglycemia and insulin autoantibodies in drug-induced lupus erythematosus. Ann Intern Med. 1983;99(2):182–184. doi:10.7326/0003-4819-99-2-182
   PubMedGoogle Scholar
• Burch HB, Clement S, Sokol MS, Landry F. Reactive hypoglycemic coma due to insulin autoimmune syndrome: case report and literature review. Am J Med. 1992;92(6):681–685. doi:10.1016/0002-9343(92)90787-C
   PubMedGoogle Scholar
• Yamada E, Okada S, Saito T, Osaki A, Ozawa A, Yamada M. Insulin autoimmune syndrome during the administration of clopidogrel. J Diabetes. 2016;8(4):588–589. doi:10.1111/1753-0407.12385
   PubMed Web of Science ®Google Scholar
• Rajpal A, Kassem LS, Moscoso-Cordero M, Arafah BM. Clopidogrel-induced insulin autoimmune syndrome: a newly recognized cause of hypoglycemia in a patient without diabetes. J Endocr Soc. 2017;1(9):1217–1223. doi:10.1210/js.2017-00316
   PubMedGoogle Scholar
• Feng X, Yuan L, Hu Y, et al. Gliclazide-induced insulin autoimmune syndrome: a rare case report and review on literature. Endocr Metab Immune Disord Drug Targets. 2016;16(4):230–234. doi:10.2174/1871530316666161223144558
   PubMedGoogle Scholar
• Okazaki-Sakai S, Yoshimoto S, Yagi K, Wakasugi T, Takeda Y, Yamagishi M. Insulin autoimmune syndrome caused by an adhesive skin patch containing loxoprofen-sodium. Intern Med. 2013;52(21):2447–2451. doi:10.2169/internalmedicine.52.0570
   PubMedGoogle Scholar
• Benson EA, Ho P, Wang C, Wu PC, Fredlund PN, Yueng RT. Insulin autoimmunity as a cause of hypoglycemia. Arch Intern Med. 1984;144(12):2351–2354. doi:10.1001/archinte.1984.00350220067015
   PubMedGoogle Scholar
• Herranz L, Rovira A, Grande C, et al. Autoimmune insulin syndrome in a patient with progressive systemic sclerosis receiving penicillamine. Horm Res. 1992;37(1–2):78–80. doi:10.1159/000182286
   PubMedGoogle Scholar
• Lidar M, Rachmani R, Half E, Ravid M. Insulin autoimmune syndrome after therapy with imipenem. Diabetes Care. 1999;22(3):524–525. doi:10.2337/diacare.22.3.524a
   PubMedGoogle Scholar
• Cavaco B, Uchigata Y, Porto T, Amparo-Santos M, Sobrinho L, Leite V. Hypoglycaemia due to insulin autoimmune syndrome: report of two cases with characterisation of HLA alleles and insulin autoantibodies. Eur J Endocrinol. 2001;145(3):311–316. doi:10.1530/eje.0.1450311
   PubMedGoogle Scholar
• Ma WY, Won JG, Tang KT, Lin HD. Severe hypoglycemic coma due to insulin autoimmune syndrome. J Chin Med Assoc. 2005;68(2):82–86. doi:10.1016/S1726-4901(09)70140-6
   PubMedGoogle Scholar
• Gopal K, Priya G, Gupta N, Praveen EP, Khadgawat R. A case of autoimmune hypoglycemia outside Japan: rare, but in the era of expanding drug-list, important to suspect. Indian J Endocrinol Metab. 2013;17(6):1117–1119. doi:10.4103/2230-8210.122644
   PubMedGoogle Scholar
• Sahni P, Trivedi N, Omer A. Insulin Autoimmune Syndrome: a rare cause of postprandial hypoglycemia. Endocrinol Diabetes Metab Case Rep. 2016;2016:16–0064.
   PubMedGoogle Scholar
• Kamei S, Kaneto H, Shigemoto R, et al. Human serum albumin: possible cause of insulin autoimmune syndrome. J Diabetes Investig. 2016;7(6):919–920. doi:10.1111/jdi.2016.7.issue-6
   PubMedGoogle Scholar
• Papanas N, Ziegler D. Efficacy of alpha-lipoic acid in diabetic neuropathy. Expert Opin Pharmacother. 2014;15(18):2721–2731. doi:10.1517/14656566.2014.972935
   PubMed Web of Science ®Google Scholar
• Vallianou N, Evangelopoulos A, Koutalas P. Alpha-lipoic acid and diabetic neuropathy. Rev Diabet Stud. 2009;6(4):230–236. doi:10.1900/RDS.2009.6.230
   PubMedGoogle Scholar
• Pieralice S, Vari R, Minutolo A, et al. Biomarkers of response to alpha-lipoic acid ± palmitoiletanolamide treatment in patients with diabetes and symptoms of peripheral neuropathy. Endocrine. 2019;66(2):178–184. doi:10.1007/s12020-019-01917-w
   PubMedGoogle Scholar
• Fruzzetti F, Fidecicchi T, Palla G, Gambacciani M. Long-term treatment with alpha-lipoic acid and myo-inositol positively affects clinical and metabolic features of polycystic ovary syndrome. Gynecol Endocrinol. 2020;36(2):152–155. doi:10.1080/09513590.2019.1640673
   PubMed Web of Science ®Google Scholar
• Holmquist L, Stuchbury G, Berbaum K, et al. Lipoic acid as a novel treatment for Alzheimer’s disease and related dementias. Pharmacol Ther. 2007;113(1):154–164. doi:10.1016/j.pharmthera.2006.07.001
   PubMed Web of Science ®Google Scholar
• Hattori N, Duhita MR, Mukai A, Matsueda M, Shimatsu A. Development of insulin antibodies and changes in titers over a long-term period in patients with type 2 diabetes. Clin Chim Acta. 2014;433:135–138. doi:10.1016/j.cca.2014.03.008
   PubMed Web of Science ®Google Scholar
• Matsushita S, Takahashi K, Motoki M, Komoriya K, Ikagawa S, Nishimura Y. Allele specificity of structural requirement for peptides bound to HLA-DRB1*0405 and -DRB1*0406 complexes: implication for the HLA-associated susceptibility to methimazole-induced insulin autoimmune syndrome. J Exp Med. 1994;180(3):873–883. doi:10.1084/jem.180.3.873
   PubMed Web of Science ®Google Scholar
• Halsall DJ, Mangi M, Soos M, et al. Hypoglycemia due to an insulin binding antibody in a patient with an IgA-kappa myeloma. J Clin Endocrinol Metab. 2007;92(6):2013–2016. doi:10.1210/jc.2007-0075
   PubMedGoogle Scholar
• Church D, Cardoso L, Bradbury S, et al. Diagnosis of insulin autoimmune syndrome using polyethylene glycol precipitation and gel filtration chromatography with ex vivo insulin exchange. Clin Endocrinol (Oxf). 2017;86(3):347–353. doi:10.1111/cen.2017.86.issue-3
   PubMedGoogle Scholar
• Moreira RO, Lima GA, Peixoto PC, Farias ML, Vaisman M. Insulin autoimmune syndrome: case report. Sao Paulo Med J. 2004;122(4):178–180. doi:10.1590/S1516-31802004000400010
   PubMedGoogle Scholar
• Elias D, Cohen IR, Schechter Y, Spirer Z, Golander A. Antibodies to insulin receptor followed by anti-idiotype. Antibodies to insulin in child with hypoglycemia. Diabetes. 1987;36(3):348–354. doi:10.2337/diab.36.3.348
   PubMedGoogle Scholar
• Eguchi Y. Scatchard analysis of insulin autoantibodies in the insulin autoimmune syndrome. J Tokyo Women’s Med Coll. 1989;59:1286–1305.
   Google Scholar
• Iizuka K, Tomita R, Horikawa Y, Takeda J. A case of glycemic instability and insulin allergy due to anti-insulin antibodies in a patient with type 2 diabetes. Diabetol Int. 2012;3(4):233–238. doi:10.1007/s13340-012-0077-8
   Google Scholar
• Tamura Y, Kimbara Y, Funatsuki S, et al. A case of insulin antibody-induced glucose instability in an elderly woman with type 2 diabetes on hemodialysis, successfully ameliorated with liraglutide. Diabetol Int. 2013;4(1):71–75. doi:10.1007/s13340-012-0100-0
   Google Scholar
• Sodoyez JC, Sodoyez-Goffaux F, Koch M, et al. Clonally restricted insulin autoantibodies in a cohort of 2200 healthy blood donors. Diabetologia. 1990;33(12):719–725. doi:10.1007/BF00400341
   PubMedGoogle Scholar
• Redmon JB, Nuttall FQ. Autoimmune hypoglycemia. Endocrinol Metab Clin North Am. 1999;28(3):603–618, vii. doi:10.1016/S0889-8529(05)70090-6
   PubMed Web of Science ®Google Scholar
• Ismail AA. The double whammy of endogenous insulin antibodies in non-diabetic subjects. Clin Chem Lab Med. 2008;46(2):153–156. doi:10.1515/CCLM.2008.031
   PubMed Web of Science ®Google Scholar
• Uchigata Y, Hirata Y. Insulin autoimmune syndrome (IAS, Hirata disease). Ann Med Interne (Paris). 1999;150(3):245–253.
   PubMedGoogle Scholar
• Martens P, Tits J. Approach to the patient with spontaneous hypoglycemia. Eur J Intern Med. 2014;25(5):415–421. doi:10.1016/j.ejim.2014.02.011
   PubMed Web of Science ®Google Scholar
• Cryer PE. Hypoglycemia, functional brain failure, and brain death. J Clin Invest. 2007;117(4):868–870. doi:10.1172/JCI31669
   PubMed Web of Science ®Google Scholar
• Vogeser M, Parhofer KG, Furst H, Jacob K, Brodl UC, Seidel D. Autoimmune hypoglycemia presenting as seizure one week after surgery. Clin Chem. 2001;47(4):795–796. doi:10.1093/clinchem/47.4.795
   PubMedGoogle Scholar
• Wong SL, Priestman A, Holmes DT. Recurrent hypoglycemia from insulin autoimmune syndrome. J Gen Intern Med. 2014;29(1):250–254. doi:10.1007/s11606-013-2588-9
   PubMed Web of Science ®Google Scholar
• International Hypoglycaemia Study G. Glucose concentrations of less than 3.0 mmol/L (54 mg/dL) should be reported in clinical trials: a joint position statement of the american diabetes association and the european association for the study of diabetes. Diabetes Care. 2017;40(1):155–157. doi:10.2337/dc16-2215
   PubMedGoogle Scholar
• Ratner RE. Hypoglycemia: new Definitions and Regulatory Implications. Diabetes Technol Ther. 2018;20(S2):S250–S253. doi:10.1089/dia.2018.0113
   PubMedGoogle Scholar
• Yuan T, Li J, Li M, et al. Insulin autoimmune syndrome diagnosis and therapy in a single chinese center. Clin Ther. 2019;41(5):920–928. doi:10.1016/j.clinthera.2019.03.009
   PubMed Web of Science ®Google Scholar
• Censi S, Albergoni MP, Gallo N, Plebani M, Boscaro M, Betterle C. Insulin autoimmune syndrome (Hirata’s disease) in an Italian patient: a case report and review of the literature. Clin Chem Lab Med. 2018;56(6):889–895. doi:10.1515/cclm-2017-0392
   PubMedGoogle Scholar
• Owen WE, Roberts WL. Cross-reactivity of three recombinant insulin analogs with five commercial insulin immunoassays. Clin Chem. 2004;50(1):257–259. doi:10.1373/clinchem.2003.026625
   PubMed Web of Science ®Google Scholar
• Marks V, Teale JD. Drug-induced hypoglycemia. Endocrinol Metab Clin North Am. 1999;28(3):555–577. doi:10.1016/S0889-8529(05)70088-8
   PubMedGoogle Scholar
• Lebowitz MR, Blumenthal SA. The molar ratio of insulin to C-peptide. An aid to the diagnosis of hypoglycemia due to surreptitious (or inadvertent) insulin administration. Arch Intern Med. 1993;153(5):650–655. doi:10.1001/archinte.1993.00410050082011
   PubMedGoogle Scholar
• Ismail AA. Testing for insulin antibodies is mandatory in the differential diagnosis of hypoglycaemia in nondiabetic subjects. Clin Endocrinol (Oxf). 2012;76(4):603–604. doi:10.1111/cen.2012.76.issue-4
   PubMedGoogle Scholar
• Scatchard G. The attractions of proteins for small molecules and ions. Ann N Y Acad Sci. 1949;51(4):660–672. doi:10.1111/nyas.1949.51.issue-4
   Web of Science ®Google Scholar
• Eguchi Y, Uchigata Y, Yao K, Yokoyama H, Hirata Y, Omori Y. Longitudinal changes of serum insulin concentration and insulin antibody features in persistent insulin autoimmune syndrome (Hirata’s disease). Autoimmunity. 1994;19(4):279–284. doi:10.3109/08916939409071354
   PubMed Web of Science ®Google Scholar
• Service FJ, McMahon MM, O’Brien PC, Ballard DJ. Functioning insulinoma–incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc. 1991;66(7):711–719. doi:10.1016/S0025-6196(12)62083-7
   PubMed Web of Science ®Google Scholar
• Grimaldi F, Fazio N, Attanasio R, et al. Italian Association of Clinical Endocrinologists (AME) position statement: a stepwise clinical approach to the diagnosis of gastroenteropancreatic neuroendocrine neoplasms. J Endocrinol Invest. 2014;37(9):875–909. doi:10.1007/s40618-014-0119-0
   PubMedGoogle Scholar
• Mehrabi A, Fischer L, Hafezi M, et al. A systematic review of localization, surgical treatment options, and outcome of insulinoma. Pancreas. 2014;43(5):675–686. doi:10.1097/MPA.0000000000000110
   PubMed Web of Science ®Google Scholar
• Service FJ, Natt N, Thompson GB, et al. Noninsulinoma pancreatogenous hypoglycemia: a novel syndrome of hyperinsulinemic hypoglycemia in adults independent of mutations in Kir6.2 and SUR1 genes. J Clin Endocrinol Metab. 1999;84(5):1582–1589. doi:10.1210/jcem.84.5.5645
   PubMedGoogle Scholar
• Thompson GB, Service FJ, Andrews JC, et al. Noninsulinoma pancreatogenous hypoglycemia syndrome: an update in 10 surgically treated patients. Surgery. 2000;128(6):937–944;discussion 944–935. doi:10.1067/msy.2000.110243
   Google Scholar
• Malik S, Mitchell JE, Steffen K, et al. Recognition and management of hyperinsulinemic hypoglycemia after bariatric surgery. Obes Res Clin Pract. 2016;10(1):1–14. doi:10.1016/j.orcp.2015.07.003
   PubMed Web of Science ®Google Scholar
• Ritz P, Hanaire H. Post-bypass hypoglycaemia: a review of current findings. Diabetes Metab. 2011;37(4):274–281. doi:10.1016/j.diabet.2011.04.003
   PubMedGoogle Scholar
• Marks V, Teale JD. Hypoglycemia: factitious and felonious. Endocrinol Metab Clin North Am. 1999;28(3):579–601. doi:10.1016/S0889-8529(05)70089-X
   PubMedGoogle Scholar
• Service FJ, Palumbo PJ. Factitial hypoglycemia. Three cases diagnosed on the basis of insulin antibodies. Arch Intern Med. 1974;134(2):336–340. doi:10.1001/archinte.1974.00320200146022
   PubMedGoogle Scholar
• Arioglu E, Andewelt A, Diabo C, Bell M, Taylor SI, Gorden P. Clinical course of the syndrome of autoantibodies to the insulin receptor (type B insulin resistance): a 28-year perspective. Medicine (Baltimore). 2002;81(2):87–100. doi:10.1097/00005792-200203000-00001
   PubMed Web of Science ®Google Scholar
• Chu JP, Zheng XW, Lu J, et al. Insulin-induced autoimmune syndrome: A case report. Exp Ther Med. 2016;12(5):3359–3362. doi:10.3892/etm.2016.3767
   PubMedGoogle Scholar
• Philippon M, Sejil S, Mugnier M, et al. Use of the continuous glucose monitoring system to treat insulin autoimmune syndrome: quantification of glucose excursions and evaluation of treatment efficacy. Diabet Med. 2014;31(7):e20–e24. doi:10.1111/dme.2014.31.issue-7
   PubMedGoogle Scholar
• Savas-Erdeve S, Yilmaz Agladioglu S, Onder A, et al. An uncommon cause of hypoglycemia: insulin autoimmune syndrome. Horm Res Paediatr. 2014;82(4):278–282. doi:10.1159/000362758
   PubMedGoogle Scholar
• Schlemper RJ, Uchigata Y, Frolich M, Vingerhoeds AC, Meinders AE. Recurrent hypoglycaemia caused by the insulin autoimmune syndrome: the first Dutch case. Neth J Med. 1996;48(5):188–192. doi:10.1016/0300-2977(95)00085-2
   PubMed Web of Science ®Google Scholar
• Church D, Cardoso L, Kay RG, et al. Assessment and management of anti-insulin autoantibodies in varying presentations of insulin autoimmune syndrome. J Clin Endocrinol Metab. 2018;103(10):3845–3855. doi:10.1210/jc.2018-00972
   PubMedGoogle Scholar
• Paiva ES, Pereira AE, Lombardi MT, et al. Insulin autoimmune syndrome (Hirata disease) as differential diagnosis in patients with hyperinsulinemic hypoglycemia. Pancreas. 2006;32(4):431–432. doi:10.1097/01.mpa.0000220872.18153.72
   PubMedGoogle Scholar
• Panikar V, Joshi S, Vadgama J, et al. Autoimmune hypoglycemia relapse on glucocorticoids, effectively treated with azathioprine. J Assoc Physicians India. 2018;66(12):78–79.
   PubMedGoogle Scholar
• Saxon DR, McDermott MT, Michels AW. Novel management of insulin autoimmune syndrome with rituximab and continuous glucose monitoring. J Clin Endocrinol Metab. 2016;101(5):1931–1934. doi:10.1210/jc.2016-1097
   PubMedGoogle Scholar
• Church D, Hunter RW, Lyall M, et al. Resolution of Hypoglycemia and Cardiovascular Dysfunction After Rituximab Treatment of Insulin Autoimmune Syndrome. Diabetes Care. 2017;40(7):e80–e82. doi:10.2337/dc17-0264
   PubMedGoogle Scholar
• Kroemer TM, Erler A, Tsourdi E, et al. Immunoadsorption followed by rituximab as a definitive treatment for insulin autoimmune syndrome (Hirata Syndrome): a case report. Diabetes Care. 2018;41(3):e23–e24. doi:10.2337/dc17-1974
   PubMedGoogle Scholar
• Yu L, Herold K, Krause-Steinrauf H, et al. Rituximab selectively suppresses specific islet antibodies. Diabetes. 2011;60(10):2560–2565. doi:10.2337/db11-0674
   PubMed Web of Science ®Google Scholar
• Dozio N, Scavini M, Beretta A, et al. Imaging of the buffering effect of insulin antibodies in the autoimmune hypoglycemic syndrome. J Clin Endocrinol Metab. 1998;83(2):643–648. doi:10.1210/jcem.83.2.4599
   PubMed Web of Science ®Google Scholar
• Yaturu S, DePrisco C, Lurie A. Severe autoimmune hypoglycemia with insulin antibodies necessitating plasmapheresis. Endocr Pract. 2004;10(1):49–54. doi:10.4158/EP.10.1.49
   PubMedGoogle Scholar
• Beck RW, Riddlesworth T, Ruedy K, et al. Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial. JAMA. 2017;317(4):371–378. doi:10.1001/jama.2016.19975
   PubMed Web of Science ®Google Scholar
• Kudva YC, Ahmann AJ, Bergenstal RM, et al. Approach to using trend arrows in the freestyle libre flash glucose monitoring systems in adults. J Endocr Soc. 2018;2(12):1320–1337. doi:10.1210/js.2018-00294
   PubMed Web of Science ®Google Scholar